RiteMED

What RiteMED does

RiteMED is a Philippine pharmaceutical company founded in 2002 and headquartered in Mandaluyong City. The company manufactures and distributes branded generic medicines across a broad therapeutic portfolio, including cardiovascular agents (Losartan, Valsartan, Amlodipine, Metoprolol), diabetes treatments (Metformin, insulin, Pioglitazone), anti-infectives (Cefaclor, Meropenem, Linezolid), NSAIDs and analgesics (Ibuprofen, Meloxicam, Diclofenac, Paracetamol, Mefenamic Acid), gastrointestinal drugs (Lansoprazole, Domperidone), respiratory and allergy products (Montelukast, Ambroxol, Loratadine), dermatologicals (Terbinafine, Tolnaftate), vitamins and supplements, and home remedies. Product pricing is positioned for mass-market affordability, with most maintenance SKUs under ₱100 and a range from ₱2.25 to ₱4,144 across the catalog.

RiteMED sells primarily through third-party retail pharmacy chains — Mercury Drug, Southstar Drug, Rose Pharmacy, and Watsons — and through e-commerce channels Lazada, Shopee, and MedExpress, giving it nationwide single-country (Philippines) distribution. The company's go-to-market combines celebrity brand ambassadorships (Coco Martin, Charo Santos-Concio on a renewed 7-year partnership), community medical missions, and content marketing through a health-information portal with articles, videos, and symptom checkers. Its core technology is generic pharmaceutical manufacturing and distribution; there is no disclosed proprietary technology, AI capability, or platform architecture beyond standard e-commerce storefronts and digital utility tools (pharmacy locator, gamot calculator).

The revenue model is straightforward unit-pricing sales of branded generic medicines to mass-market Filipino consumers through retail and online intermediaries, supplemented by CSR-driven donations and physician-engagement programs that reinforce prescription pull-through. Customer segments are horizontal: general Filipino consumers seeking affordable medicines, healthcare providers who prescribe or recommend the products, and two focused verticals — senior citizens (maintenance drugs) and pediatric patients (RiteMED for Kids line). Ownership is private and not publicly disclosed, with 501–1,000 employees and no known parent company or external funding rounds in the source data.

Name

RiteMED

Legal name

RiteMED

Website

https://ritemed.com.ph

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

501–1,000 employees

Short description

RiteMED is a Philippine branded generic pharmaceutical company, founded in 2002, selling affordable generic medicines across cardiovascular, diabetes, antibiotic, pain, and respiratory categories through nationwide pharmacy chains and e-commerce platforms.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)

akta.pro secondary industries

Specialty Pharmaceutical Distributors (HLAIAJAB), Generic Hospital & Institutional Products (HLAIABAL)

Keywords

• Generic pharmaceuticals
• Branded medicines
• Prescription medications
• Over-the-counter drugs
• Pharmaceutical distribution

Headquarters

HQ city

Mandaluyong

HQ country

Philippines

HQ region

Asia

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

1. Branded Generic Medicines Sales: RiteMED generates revenue through the sale of branded generic medicines across multiple therapeutic categories including cardiovascular, diabetes, antibiotics, pain management, respiratory, and dermatological products. Products are sold through retail pharmacies, drugstores, and online marketplaces in the Philippines.

Pricing tiers

Go-to-market motion2 records

Distribution channels7 records

Marketing channels5 records

Core offering

RiteMED manufactures and distributes branded generic pharmaceutical products in the Philippines across major therapeutic categories including cardiovascular, antidiabetic, antibiotic, analgesic, antipyretic, mucolytic, and dermatological treatments. The company offers prescription and over-the-counter medicines bearing the "RM" brand prefix and sells them through national pharmacy chains and major e-commerce platforms.

Product overview

RiteMED is a Philippine pharmaceutical company offering a comprehensive portfolio of branded generic medicines positioned as affordable, high-quality alternatives. The product portfolio spans multiple therapeutic categories including cardiovascular medications (RM Metoprolol Tartrate, RM Losartan, RM Valsartan, RM Amlodipine, RM Simvastatin), diabetes management (RM Metformin, RM Insulyf insulin, RM Pioglitazone), anti-infectives (RM Cefaclor, RM Meropenem, RM Linezolid, RM Doxycycline, RM Metronidazole), pain and arthritis treatments (RM Ibuprofen, RM Meloxicam, RM Diclofenac Sodium, RM Mefenamic Acid), gastrointestinal medications (RM Lansoprazole, RM Domperidone, RM Hyoscine), respiratory/allergy products (RM Montelukast, RM Ambroxol, RM Loratadine), dermatologicals (RM Terbinafine, RM Tolnaftate), vitamins and supplements (RM Vitamin B Complex, RM Ascorbic Acid), kidney supplements (RM Remoston/Sambong), and home remedies (RM Isopropyl Alcohol). The company distributes through retail pharmacies nationwide including Mercury Drug, Southstar Drug, Rose Pharmacy, Watsons, and online platforms such as Lazada and Shopee.

Differentiator

Problem solved

Functional benefit

Products and services

• RM Acyclovir
• RM Ambroxol
• RM Ascorbic Acid
• RM Carbocisteine
• RM Cefalexin
• RM Ibuprofen
• RM Metoprolol

Quantifiable outcome

• 23 years of operation in the Philippine pharmaceutical market
• +1 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Five partnerships are on record, tiered core and minor.

• Charo Santos-ConciocoreGTM or Marketing Partner · 31 September 2025Charo Santos-Concio has maintained a 7-year partnership with RiteMED as brand ambassador, championing the cause of accessible, high-quality, and affordable medicines for Filipino families. The partnership was renewed in September 2025.
• Coco MartincoreGTM or Marketing Partner · 1 September 2025Coco Martin serves as RiteMED's brand ambassador, supporting the company's advocacy 'Gusto Namin Gumaling Kayo' (We Want You to Get Better). His involvement includes participation in medical missions and community health outreach programs to promote accessible, affordable medicines to Filipino families.
• Manila City Government / Mayor Francisco 'Isko' Moreno DomagosominorOthersRiteMED donated ₱1.1 million worth of maintenance medicines to senior citizens of Manila. The city government, through Mayor Domagoso, officially accepted the donation, demonstrating community partnership for healthcare access.
• Diosdado P. Macapagal Elementary School, Brgy. Tatalon, Quezon CityminorOthersSite of RiteMED's 23rd anniversary mega medical mission in partnership with brand ambassador Coco Martin, providing healthcare support to local community members.
• Philippine College of Physicians (PCP)minorStrategic or Co-development PartnerRiteMED participated in the 55th PCP Annual Convention held May 4-7, 2025 at SMX Convention Center, showcasing products and educational materials to internists, diplomates, and physicians to reinforce advocacy for quality, accessible medicines among the medical community.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• Glenmark Pharmaceuticals: Indian-headquartered generic and specialty pharma with established Philippines operations, offering branded generics in respiratory, dermatology, and cardiovascular. Direct regional competitor to RiteMED in the Philippine market.

Direct peers

• Unilab (United Laboratories Inc.): The largest pharmaceutical company in the Philippines, offering a broad portfolio of branded generics and OTC products across similar therapeutic categories. Unilab is RiteMED's closest direct competitor, commanding dominant retail pharmacy share in the same channels.
• Pascual Laboratories (Pascual Consumer Healthcare): A major Philippine pharmaceutical manufacturer and marketer of branded generics, vitamins, and OTC products. Comparable in scale and channel strategy, serving the same Filipino consumer base through retail pharmacy distribution.

Broad incumbents

• Cipla: Major Indian generic pharmaceutical manufacturer with strong emerging markets focus, exporting to the Philippines and other Southeast Asian countries across respiratory, anti-infectives, and cardiovascular generics.
• Teva Pharmaceutical Industries: The world's largest generic drug manufacturer with a broad finished dosage form portfolio spanning cardiovascular, anti-infectives, CNS, and respiratory categories. While not focused on the Philippine mass market, it competes in the same generic molecules RiteMED sells.
• Viatris: Global healthcare company formed from Mylan and Upjohn, with one of the world's largest generic medicine portfolios and significant emerging-market presence. Competes with RiteMED in generics across cardiovascular, anti-infectives, and other categories.
• Stada Arzneimittel: European-based generics and consumer healthcare company with growing presence in emerging markets, including Southeast Asia. Comparable in branded generic strategy and therapeutic category coverage.
• Lupin Pharmaceuticals: Major Indian generic pharmaceutical company with strengths in cardiovascular, diabetes, and anti-infectives generics. Exports into the Philippines and Southeast Asia with comparable molecule coverage to RiteMED.
• Sandoz: The generic pharmaceuticals division of Novartis, a global leader in generic and biosimilar medicines. Operates across the same small-molecule generic categories as RiteMED with global manufacturing scale.
• Aurobindo Pharma: One of India's largest generic manufacturers with a broad finished dosage form portfolio across antibiotics, cardiovascular, and CNS. Active exporter to the Philippines and competing in the same generic categories.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/ritemedicine
• Facebookfacebook.com/RiteMedOfficialPage

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RiteMED